BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30
• 31

• Business

  Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update

  Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today provided a business update and reported financial results for the quarter ended March 31, 2023.

  May 15, 2023

   · 

  11 min read
• Business

  TherapeuticsMD Announces First Quarter 2023 Financial Results

  TherapeuticsMD, Inc., a company that owns rights to pharmaceutical royalties, reported financial results for the first quarter ended March 31, 2023.

  May 15, 2023

   · 

  4 min read
• Business

  Onconova Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Update

  Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on discovering and developing novel products for patients with cancer, announced financial results for the three months ended March 31, 2023, and provided a business update.

  May 15, 2023

   · 

  9 min read
• Business

  Tivic Reports First Quarter 2023 Financial Results

  Tivic Health® Systems, Inc., a health tech company that develops and commercializes bioelectronic medicine, is pleased to announce its financial results for the first quarter of 2023 ended March 31, 2023.

  May 15, 2023

   · 

  9 min read
• Business

  Precision Optics Reports Third Quarter Fiscal Year 2023 Financial Results

  Precision Optics Corporation, Inc. (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense industries, announced operating results on an unaudited basis for its third quarter fiscal year 2023.

  May 15, 2023

   · 

  12 min read
• Business

  DiaMedica Therapeutics Provides a Business Update and Announces First Quarter 2023 Financial Results

  DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for neurological disorders and kidney diseases, today provided a business update and financial results for the quarter ended March 31, 2023.

  May 15, 2023

   · 

  16 min read
• Business

  Vaccinex Reports First Quarter 2023 Financial Results and Provides Corporate Update

  Vaccinex, Inc. (Nasdaq: VCNX) today announced financial results for the first quarter ended March 31, 2023 and provided a corporate update on key programs and financing in the first five months of the year.

  May 15, 2023

   · 

  15 min read
• Business

  Adamis Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Corporate Update

  Adamis Pharmaceuticals Corporation announced financial results for the first quarter ended March 31, 2023, and provided an update on recent corporate developments.

  May 15, 2023

   · 

  10 min read
• Business

  BiondVax Announces First Quarter 2023 Financial Results and Provides Business Update

  BiondVax Pharmaceuticals Ltd. (Nasdaq:BVXV) today published its financial results for the first quarter ended March 31, 2023, and provided a business update.

  May 15, 2023

   · 

  7 min read
• Business

  ProMIS Neurosciences Announces First Quarter 2023 Financial Results and Recent Highlights

  ProMIS Neurosciences Inc. (TSX: PMN) (Nasdaq: PMN) today announced its first quarter 2023 financial results and recent highlights.

  May 15, 2023

   · 

  9 min read